NCT00049413View on ClinicalTrials.gov

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2002

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2005

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

pentostatin

Trial Locations (1)

92658

Hoag Cancer Center at Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
collaborator

Cancer Biotherapy Research Group

OTHER

lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00049413 - Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma | Biotech Hunter | Biotech Hunter